XML 22 R10.htm IDEA: XBRL DOCUMENT
v3.25.3

Investments | 9 Months Ended
--- | ---
Sep. 30, 2025
Cash and Cash Equivalents [Abstract] |
Investments | Investments Cash equivalents and marketable securities are classified as available-for-sale and are recorded at fair value on the condensed consolidated balance sheets, with any unrealized gains and losses reported in accumulated other comprehensive loss, which is reflected as a separate component of stockholders’ equity on the Company’s condensed consolidated balance sheets, until realized. The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. The Company considers all marketable securities to be current assets as they are available for use in current operations. The amortized cost and fair value of investments are as follows (in thousands):
| September 30, 2025
| Amortized cost |  | Gross unrealized gains |  | Gross unrealized losses |  | Fair market value
Assets |  |  |  |  |  |  |
Money market funds | $ | 192 |  |  | $ | — |  |  | $ | — |  |  | $ | 192 |
U.S. treasuries | 142,849 |  |  | 164 |  |  | (14) |  |  | 142,999 |
Total | $ | 143,041 |  |  | $ | 164 |  |  | $ | (14) |  |  | $ | 143,191 |
Classified as: |  |  |  |  |  |  |
Cash equivalents |  |  |  |  |  |  | $ | 192 |
Marketable securities |  |  |  |  |  |  | 142,999 |
Total |  |  |  |  |  |  | $ | 143,191 |
| December 31, 2024
| Amortized cost |  | Gross unrealized gains |  | Gross unrealized losses |  | Fair market value
Assets |  |  |  |  |  |  |
Money market funds | $ | 2,134 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,134 |
U.S. treasuries | 71,151 |  |  | 61 |  |  | — |  |  | 71,212 |
Total | $ | 73,285 |  |  | $ | 61 |  |  | $ | — |  |  | $ | 73,346 |
Classified as: |  |  |  |  |  |  |
Cash equivalents |  |  |  |  |  |  | $ | 2,134 |
Marketable securities |  |  |  |  |  |  | 71,212 |
Total |  |  |  |  |  |  | $ | 73,346 |
Proceeds from maturities of available-for-sale securities were $39.0 million and $65.2 million for the three and nine months ended September 30, 2025, respectively. Proceeds from maturities of available-for-sale securities were $43.0 million and $132.1 million for the three and nine months ended September 30, 2024, respectively. As of September 30, 2025, the Company held $32.6 million of marketable securities with a remaining maturity of greater than one year. There were no realized gains or losses on securities for the three and nine months ended September 30, 2025 and 2024. Unrealized gains and losses on securities were primarily due to changes in interest rates.

X
- References No definition available. + Details
Name: | us-gaap_CashAndCashEquivalentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for cash, cash equivalent, investment in debt and equity securities, equity method investment, investment in joint venture, and investment classified as other. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 13 -Subparagraph (d)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13 + Details
Name: | us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration